Antineoplastic Agent Lenalidomide Powder CAS 191732-72-6 with Good Quality
Product Description
Antineoplastic Agent Lenalidomide Powder CAS 191732-72-6 with Good Quality
Product Description
| Lenalidomide Basic information | |
| Antitumor Drug | |
| Product Name: | Lenalidomide (Anti Cancer Drug) |
| Synonyms: | Revlimid;Lenalidomide ,98%;3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione;3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione,Lenalidomide;LenalidoMide(CC-5013,RevliMid);(3S)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione;3-(4-aMino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione;(3R)-3-(4-aMino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione |
| CAS: | 191732-72-6 |
| MF: | C13H13N3O3 |
| MW: | 259.26062 |
| EINECS: | 691-297-1 |
| Product Categories: | Intermediates & Fine Chemicals;Pharmaceuticals;Amines;Heterocycles;Inhibitor;CC-5013;Inhibitors;-;Molecular Targeted Antineoplastic;pharmaceutical intermediate |
| Lenalidomide Chemical Properties | |
| Melting point | 269-271°C |
| storage temp. | -20°C Freezer |
| CAS DataBase Reference | 191732-72-6(CAS DataBase Reference) |
Function:
The product is used to treat morning sickness has caused thousands of birth defects Thalidomide (thalidomide) enhanced version, with anti-cancer potential. Compared with thalidomide, fewer adverse reactions, studies have shown that it does not cause birth defects.
Application:
The product is used to treat morning sickness has caused thousands of birth defects Thalidomide (thalidomide) enhanced version, with anti-cancer potential. Compared with thalidomide, fewer adverse reactions, studies have shown that it does not cause birth defects.
Packing and Shipping: